Page last updated: 2024-10-29

ketanserin and Air Embolism

ketanserin has been researched along with Air Embolism in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Serotonin can induce pulmonary hypertension, hypoxia and bronchoconstriction, and ketanserin has been shown to reverse these effects on various experimental models of acute respiratory failure."3.67Effects of serotonin inhibition in air embolism in dogs. ( Domb, M; Goldstein, J; Lignan, H; Vincent, JL, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalenda, Z1
Hölzenspies, AJ1
Vincent, JL1
Goldstein, J1
Domb, M1
Lignan, H1

Other Studies

2 other studies available for ketanserin and Air Embolism

ArticleYear
Restoration of pulmonary perfusion by a serotonin antagonist.
    Angiology, 1981, Volume: 32, Issue:7

    Topics: Adult; Aged; Blood Pressure; Carbon Dioxide; Embolism, Air; Female; Humans; Infant, Newborn; Intraop

1981
Effects of serotonin inhibition in air embolism in dogs.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1988, Volume: 20, Issue:3

    Topics: Animals; Blood Pressure; Dogs; Embolism, Air; Hypertension, Pulmonary; Hypoxia; Ketanserin; Serotoni

1988